Epsiprantel
319 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
319
Total Reports
15
Deaths Reported
470.0%
Death Rate
Active Ingredients
Epsiprantel
Administration Routes
OralUnknownParenteralOther
Species Affected
Dog 222
Cat 93
Unknown 3
Human 1
Most Affected Breeds
Domestic Shorthair 54
Crossbred Canine/dog 19
Retriever - Labrador 19
Dog (unknown) 13
Chihuahua 12
Terrier - Yorkshire 9
Spitz - German Pomeranian 9
Cat (unknown) 8
Retriever - Golden 8
Shih Tzu 7
Most Reported Reactions
Lack of efficacy (endoparasite) - tapeworm 149
Vomiting 59
Emesis 26
Lethargy (see also Central nervous system depression in 'Neurological') 23
Overdose 23
Lack of efficacy - NOS 19
Lack of efficacy (tapeworm) 19
Anorexia 18
Diarrhoea 15
Death 9
Lack of efficacy (ectoparasite) - flea 9
Ataxia 8
Outcome Breakdown
Ongoing
114 (40.0%)
Outcome Unknown
79 (27.7%)
Recovered/Normal
75 (26.3%)
Died
12 (4.2%)
Euthanized
3 (1.1%)
Recovered with Sequela
2 (0.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.